A SMYD3 Small‐Molecule Inhibitor Impairing Cancer Cell Growth
Alessia Peserico(University of Teramo), Cristiano Simone(Gastroenterology Hospital "Saverio de Bellis")
Cited by 128
Related Papers
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy
|Cell Death and Disease|2018|55
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
|iScience|2020|25
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
|Journal of Experimental & Clinical Cancer Research|2024|8
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis
|Signal Transduction and Targeted Therapy|2025|7